Klaus Lieb



Lieb, Klaus, Prof. Dr. Department of Psychiatry and Psychotherapy Johannes Gutenberg University Medical Center Mainz Untere Zahlbacher Str. 8, Bldg. 920 55131 Mainz Phone: +49 (0)6131 17-7335 Email: [email protected] Current position: Professor (W3) and director of Department of Psychiatry and Psychotherapy Academic education with degree 1999 Habilitation in Psychiatry, University of Freiburg (supervisor: M. Berger) 1992 Dr. med.: Medicine, University of Ulm (supervisor: H.L. Fehm, Ulm) 10/1985 – 09/1992 Human Medicine and Philosophy, University of Ulm, Tübingen and Los Angeles. Professional career since 04/2007 Professor for Psychiatry and Psychotherapy (W3) and director Department of Psychiatry and Psychotherapy, Mainz 06/2001 – 03/2007 Chief Physician and Vice Chairman at the Department of Psychiatry and Psychotherapy of the University Medical Center Freiburg 02/1999 - 05/2001 Consultant psychiatrist and group leader, University Medical Center Freiburg 09/1994 – 02/1999 Research assistant/Junior doctor at the Psychiatric University Hospital, Freiburg 09/1994 – 08/1995 Postdoctoral fellow of the German Research Foundation (DFG) in the Neurobiology Laboratory of the University Hospital for Psychiatry, Freiburg 10/1992 – 09/1994 Postdoctoral fellow, Department of Anatomy and Cell Biology/Internal Medicine, University of Ulm, Germany (supervisor: C. Pilgrim, G. Adler) Other 2013 Hochschullehrer des Jahres (Deutscher Hochschulverband) 2013 Hamburger Preis Persönlichkeitsstörungen Since 2009 Official member of the Drug Commission/German Medical Association Since 2009 Editor Cochrane Library of systematic reviews (section personality disorders) 2004 Golden Helix Award 5 best publications of the last 5 years Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM (2010) Pharmacotherapy for Borderline Personality Disorder. Cochrane systematic review of randomised trials. Br J Psychiatry 196: 4-12 Stoffers JM, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K (2012) Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev 8:CD005652. Schaefer M, Sarkar R, Knop V, Effenberger S, Lieb K, et al. (2012) Escitalopram for the Prevention of Peginterferon Alfa-2a Associated Depression in HCV-infected patients without previous psychiatric disease: a randomized trial. Ann Int Med 157: 94-103 Franke AG, Bagusat C, Dietz P, Hoffmann I, Simon P, Ulrich R, Lieb K (2013): Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons. BMC Medicine 11:102 doi:10.1186/1741-7015-11-102 Tadic A, Müller-Engling L, Schlicht KF, Kotsiari A, Dreimüller N, Kleimann A, Bleich S, Lieb K, Frieling H (2014): Methylation of the promotor of brain-derived neurotrophic factor exon IV and antidepressant response in major depression. Mol Psychiatry 19(3):281-3.

Record last modified Sep 20, 2018 4:01:53 AM